DalsnaFinance › IPOs › Scribe Therapeutics, Inc. › IPO
Scribe Therapeutics, Inc. completed its initial public offering on Nasdaq on July 21, 2026, pricing at $15.00 a share.
| Ticker | SCTX |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | July 21, 2026 |
| Offering price | $15.00 |
| Sector | Biological Products, (No Diagnostic Substances) |
Scribe Therapeutics, Inc. listed on Nasdaq on 2026-07-21.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 1853921.
Scribe Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Scribe Therapeutics, Inc.. This page is general information, not investment advice.